CIK 0001828673 · <br>Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825024477
- Phone
- 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-01 | Flowers Lee SVP of Business Development | Option exercise | +4,285 | $0.14 | $600 | 95,952 |
| 2021-12-01 | Flowers Lee SVP of Business Development | Option exercise · Stock Option (Right to Buy) | −4,285 | 12,857 | ||
| 2021-11-23 | Byam Rebecca Chief Financial Officer | Option exercise | +27,000 | $0.14 | $4K | 89,000 |
| 2021-11-23 | Byam Rebecca Chief Financial Officer | Option exercise · Stock Option Grant (Right to Buy) | −27,000 | 80,999 | ||
| 2021-10-26 | Winer Gary M Director | Grant or award · Stock Option | +37,037 | 37,037 | ||
| 2021-10-26 | Winer Gary M Director | Grant or award · Stock Option | +30,037 | 30,037 | ||
| 2021-10-26 | Giles Lisa M. Director | Grant or award · Stock Option | +37,037 | 37,037 | ||
| 2021-09-15 | Medmira Capital Ltd. 10% owner | Other disposition | −3,587,659 | 0 | ||
| 2021-09-08 | Byam Rebecca Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-09-08 | Rhode Peter See Remarks | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-09-08 | Flowers Lee SVP of Business Development | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-09-08 | Jiao Jin-an VP of Development | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-09-08 | Wong Hing C Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2021-08-31 | Wong Hing C Chief Executive Officer | Purchase | +5,830 | $3.94 | $23K | 15,281,948 |
| 2021-08-31 | Wong Hing C Chief Executive Officer | Purchase | +3,830 | $3.93 | $15K | 15,277,948 |
| 2021-08-30 | Wong Hing C Chief Executive Officer | Purchase | +6,000 | $3.93 | $24K | 15,274,118 |
| 2021-08-29 | Byam Rebecca Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2021-08-27 | Wong Hing C Chief Executive Officer | Purchase | +8,000 | $3.76 | $30K | 15,270,118 |
| 2021-08-27 | Wong Hing C Chief Executive Officer | Purchase | +6,000 | $3.77 | $23K | 15,268,118 |
| 2021-08-26 | Wong Hing C Chief Executive Officer | Purchase | +6,500 | $3.84 | $25K | 15,262,118 |
Page 7 of 9 · 164 trades